Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Newegg Commerce, Inc. (NEGG)

Dehaier Medical names Charles Li CFO; Aileen Qi moves to vice president

Neutral Impact 4 of 5 leadership Written later

Dehaier Medical Systems Limited (NASDAQ: DHRM) said its internal promotions took effect December 28, 2012, naming Charles (Jingli) Li as Chief Financial Officer, the principal financial and accounting officer, and moving Aileen (Yanying) Qi from that role to Vice President. The filing is attributed to Dehaier Medical, not Newegg, and it does not mention Newegg or the NEGG ticker. The filing contains no financial results, guidance, or compensation terms, so it gives shareholders no direct financial figures.

Key points

  • Charles (Jingli) Li, age 27, moved from Internal Controls Manager to CFO effective December 28, 2012
  • Aileen (Yanying) Qi moved from CFO to Vice President effective December 28, 2012
  • The 8-K reports no financial results, guidance, or compensation terms
  • Filer is Dehaier Medical Systems Limited (NASDAQ: DHRM), which does not match the NEGG ticker in the request

The filing

CompanyNewegg Commerce, Inc. (NEGG)
Form8-K, current report
Filed with the SECJan 4, 2013, 4:30 PM ET
Accession number0001144204-13-000799

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 04, 2013.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.